Clinical trial
Simultaneous Boost in Neoadjuvant Radiotherapy for Rectal Cancer:A Phase 2, Randomized Controlled Study
NCT07200141 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Simultaneous Boost in Neoadjuvant Radiotherapy for Rectal Cancer:A Phase 2, Randomized Controlled Study
- Lead sponsor
- Peking Union Medical College Hospital
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- October 1, 2025
- Completion date
- December 1, 2028
- Enrollment
- 156 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
locally advanced rectal adenocarcinoma